To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.

Stock up and Save

Take advantage of our limited-time sales event on life science essentials. Don’t wait too long to order—this exclusive offer ends December 31, 2020!

Learn more

SARS-CoV-2 Antibody – New!

Polyclonal antibody prepared against the spike glycoprotein of SARS-CoV-2 (Wuhan-Hu-1)

Available now

Hand holding a light bulb with an illustration of a brain in it

Innovation Challenge

Time is almost up—the ATCC Innovation Challenge is coming to an end on December 4, 2020. Submit your proposal today for a chance to win a share of $25,000 in products!

Submit now

Genomic Analysis of SARS-CoV-2

Read this novel study to explore the genomic analysis of the SARS-CoV-2 Hong Kong strain and what these results mean for the laboratory adaptation of clinical viruses.

Read now

Organoid Tutorial

Working with organoids can be challenging. View our tutorial video for expert tips on how to thaw, culture, and cryopreserve these advanced cell models.

View now

Bacterial Culture Fundamentals

Watch the on-demand webinar for an in-depth look at the various methods used to culture difficult-to-grow bacterial species.

Watch now

EMT Models

Want to monitor the transition from the epithelial to mesenchymal phenotype in real-time? Discover how EMT reporter knock-in cell lines can help!

Discover now

Solutions

Federal

Incredible 2020

Events

Webinars

Therapeutic Development

Human mesenchymal stem cells provide a promising technology for the treatment of acute respiratory distress syndrome, pneumonia, and acute lung injury. Incorporate these cells into your research today!

Vaccine Development

Using CRISPR/Cas9 gene-editing technology, we developed STAT1 knockout cell lines capable of producing high-titer viral stocks. Explore the use of these models in your vaccine research.

Molecular-based Assays

Explore a growing collection of BSL-1 and BSL-2 COVID-19 controls, including a heat-inactivated strain and genomic RNA prepared from the 2019-nCoV/USA-WA1/2020 strain and synthetic SARS-CoV-2 RNA.

FDA/EUA Assay Development

Determine the analytical specificity of your assays by performing cross-reactivity testing with viral, fungal, and bacterial species listed in the FDA EUA. Explore our extensive portfolio.

Primary cells

Choose from our extensive catalog of primary cells from normal and diseased lung tissue. Our collection includes airway epithelial cells, smooth muscle cells, and fibroblasts as well as supporting media and growth kits.

Immune cells

Study the interactions between SARS-CoV-2 and the immune system with human PBMCs, luciferase-labeled monocytes, NK cells, helper T cells, B cells, and cytotoxic T cells from ATCC!

ATCC employee opening a biorepository tank

Biorepository Services^SM

We’ll take care of the logistics and resources needed to keep your COVID-19 materials safe, so you can focus on what’s important—your research.

Custom Controls & Derivatives

We can design and produce external controls and derivatives in a variety of formats to help you verify, validate, and/or routinely monitor the performance of your workflow and assay.

Enhanced Authentication Initiative

ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.

ATCC Genome Portal

The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. With a free account, you can easily search, download, and analyze hundreds of high-quality genomes.

Exosomes

ATCC offers exosomes derived from well-authenticated cell lines and hTERT-immortalized mesenchymal stem cells. These extracellular vesicles can be used as standards for diagnostics development, disease marker studies, and vaccine development.